Press release
Spaulding Clinical Research Announces Addition to Cardiac Core Lab Management Team
June 07, 2016 - West Bend, Wisconsin, USA - Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced the addition of Shane Braninburg as Senior Director of Core Lab Services. Mr. Braninburg brings more than 15 years of global business expertise to Spaulding, including extensive operational and management experience at two of the largest cardiac core labs in the world.
Prior to joining Spaulding Clinical Research, Mr. Braninburg was the Senior Director of Business Process Improvement at ERT, where he was responsible for launching ERT’s centralized surveillance product across respiratory, cardiac and clinical outcome lines of business. His previous roles at ERT include Senior Director of Site Management and Director of Operations, Digital ECG Laboratory.
“Shane is a proven strategic planner with the skills needed to complement our rapid growth and sustain the quality of work our clients’ expect,” said Randol Spaulding, Founder and CEO of Spaulding Clinical Research. “With the recent FDA 510(k) Clearance of our 12-lead Bluetooth™ electrocardiograph device and the addition of Shane to the team, we’re delivering the innovative solutions the industry is looking for and the expertise necessary to deliver results.”
About Spaulding Clinical Research, LLC
Spaulding Clinical Research, LLC is a global CRO providing Phase I - IV drug development services to the biotechnology and pharmaceutical industries. Spaulding Clinical Research operates a 200-bed Clinical Pharmacology Unit, Cardiac Core Laboratory and provides full Biometrics/Scientific Affairs services.
Spaulding Clinical Research, LLC
525 S. Silverbrook Drive
West Bend, WI 53095
262.334.6020
info[at]spauldingclinical.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spaulding Clinical Research Announces Addition to Cardiac Core Lab Management Team here
News-ID: 343728 • Views: …
More Releases from Spaulding Clinical Research, LLC
Spaulding Clinical Research Named “Best Phase I Drug Development CRO”
Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, has been recognized as the Best Phase I Drug Development CRO in the 2016 International Life Sciences Awards. Spaulding Clinical Research was selected by an expert panel and based on customer reviews, capabilities, previous accolades and overall company performance.
The International Life Sciences Awards, sponsored by Global Health & Pharma (GHP) Magazine, “recognize the exceptional work of…
Spaulding Clinical to Disrupt Cardiac Safety Industry with Latest Innovation at …
Wireless, hand-held electrocardiograph designed to simplify the collection and transmission of ECG data for Pharmaceutical Sponsors
June 23, 2016 - West Bend, Wisconsin, USA - Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced that the Spaulding Electrocardiograph 2100iQ™ is to be exhibited at the Drug Information Association’s (DIA) 2016 conference.
The Spaulding 12-Lead ECG product line was originally launched in…
Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device
Wireless, hand-held electrocardiograph designed to streamline the collection and transmission of ECG data for doctors and patients.
May 24, 2016 - West Bend, Wisconsin, USA - Spaulding Medical, LLC, a wholly owned subsidiary of Spaulding Clinical Research, LLC and provider of cardiac safety solutions, today announced the FDA 510(k) Clearance for their newest 12-Lead ECG device: the Spaulding Electrocardiograph 2100iQ™.
The Spaulding 12-Lead ECG product line was originally launched in 2011 and…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
